Bioactivity and safety of chimeric switch receptor T cells in glioblastoma patients.

Guo, Jun-Xiu

Bioactivity and safety of chimeric switch receptor T cells in glioblastoma patients. [electronic resource] - Frontiers in bioscience (Landmark edition) 06 2019 - 1158-1166 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

2768-6698

10.2741/4772 doi


Adult
Aged
Brain Neoplasms--immunology
Female
Glioblastoma--immunology
Humans
Immunotherapy, Adoptive--methods
Interferon-gamma--blood
Interleukin-6--blood
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Recurrence, Local
Receptors, Chimeric Antigen--immunology
Treatment Outcome